Safety Study of VM206RY in Subjects With Expression of HER2 in Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: VM206DNA|BIOLOGICAL: VM206Ad
Sponsor: Reyon Pharmaceutical Co., Ltd.